Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
2022 · Signal Transduction and Targeted Therapy · 236 citations
https://doi.org/10.1038/s41392-022-01042-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
1.5K
Citations
20
h-index
35
i10-index
Weidong Xu is an academic researcher from Xuzhou Medical College. The author has contributed to research in topics: Spondyloarthritis Studies and Treatments & Rheumatoid Arthritis Research and Therapies & Total Knee Arthroplasty Outcomes. The author has an h-index of 20, co-authored 74 publications.
https://doi.org/10.1038/s41392-022-01042-7
https://doi.org/10.1186/s13018-016-0424-8
https://doi.org/10.1016/j.tifs.2025.105002
Click to start Chat